Back to Results

BNB Plus Corp (BNBX)

BNB Plus Corp. is a common stock listing of a company with operations in digital asset treasury services and life sciences technologies. Through its subsidiaries, the company provides real-time tracking of treasury performance and market indicators, while also developing and commercializing technologies for the production and detection of DNA and RNA. Its life sciences activities include enzymatic manufacturing of synthetic DNA for nucleic acid-based therapeutics and solutions for the biopharmaceutical and diagnostics industries, along with products and technologies such as LineaDNA, LineaRNAP, and LineaIVT. The company also develops a proprietary RNAP used in mRNA therapeutics production. Formerly known as Applied DNA Sciences, Inc., the company adopted the BNB Plus Corp. name in November 2025. Founded in 1983, it is based in Stony Brook, New York, and its operations extend across the Americas, Europe, Asia, and other international markets.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-BNBX
$0.16
78.7% Upside
Bargain
—
—
—
Weak
—
—
—
0.0%
August 13, 2026
0.0x
0.1x
0.4x
755.708 K
-568.988 K
0.0%
98.6%
-100.4
—
27.4%
Valuation • Fair Value

BNB Plus Corp (OTC-BNBX) Fair Value by Valuation Model

Compare the primary fair value estimate for BNB Plus Corp (OTC-BNBX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.16

Estimated upside of 78.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.16

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for BNB Plus Corp (OTC-BNBX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for BNB Plus Corp (OTC-BNBX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.093 M

Current operating scale indicator.

Revenue Forecast

7.398 M

Forward revenue estimate.

EBITDA

-32.128 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review BNB Plus Corp (OTC-BNBX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for BNB Plus Corp (OTC-BNBX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-14.30

No elevated caution signal from this screen.

Altman Z-Score

-100.4

Lower score that deserves closer risk review.

FCF / Net Income

27.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for BNB Plus Corp (OTC-BNBX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for BNB Plus Corp (OTC-BNBX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 13, 2026

Days to Earnings

23

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for BNB Plus Corp (OTC-BNBX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

BNB Plus Corp (OTC-BNBX) Stock Forecast & Technical Outlook

Review BNB Plus Corp (OTC-BNBX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for BNB Plus Corp (OTC-BNBX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for BNB Plus Corp (OTC-BNBX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for BNB Plus Corp (OTC-BNBX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for BNB Plus Corp (OTC-BNBX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for BNB Plus Corp (OTC-BNBX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for BNB Plus Corp (OTC-BNBX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, BNB Plus Corp (OTC-BNBX) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

BNB Plus Corp (OTC-BNBX) Stock FAQ

Quick answers about BNB Plus Corp (OTC-BNBX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.16
Estimated upside 78.7%
Valuation Rating
Undervalued
Estimated upside of 78.7%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for BNB Plus Corp (OTC-BNBX) is $0.16. This implies an estimated upside of 78.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 78.7% versus the current market price.

An analyst price target for BNB Plus Corp (OTC-BNBX) is not currently available in the latest data file.

The current financial health read for BNB Plus Corp (OTC-BNBX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for BNB Plus Corp (OTC-BNBX) is August 13, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for BNB Plus Corp (OTC-BNBX) is 0.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for BNB Plus Corp is 755.708 K.

The current enterprise value listed for BNB Plus Corp is -568.988 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for BNB Plus Corp is OTC-BNBX, and the stock is listed on OTC Markets.

BNB Plus Corp (OTC-BNBX) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for BNB Plus Corp is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for BNB Plus Corp is 98.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on OTC Markets View more

Lonza Group AG (LZAGY) Lonza Group AG (LZAGY)
WuXi Biologics (WXIBF) WuXi Biologics (WXIBF)
RADNOSTIX, INC (INIS) RADNOSTIX, INC (INIS)
Malin Corporation plc (MLLNF) Malin Corporation plc (MLLNF)
Bioqual Inc (BIOQ) Bioqual Inc (BIOQ)
Sona Nanotech Inc (SNANF) Sona Nanotech Inc (SNANF)
Pharma-Bio Serv Inc (PBSV) Pharma-Bio Serv Inc (PBSV)
Reflect Scientific Inc (RSCF) Reflect Scientific Inc (RSCF)
Cannabis Bioscience International Holdings Inc (CBIH) Cannabis Bioscience International Holdings Inc (CBIH)
Pressure Biosciences Inc (PBIO) Pressure Biosciences Inc (PBIO)
EVIO Inc (EVIO) EVIO Inc (EVIO)
MetaStat Inc (MTST) MetaStat Inc (MTST)
Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO)
BG Medicine Inc (BGMD) BG Medicine Inc (BGMD)
Arrayit Corporation (ARYC) Arrayit Corporation (ARYC)
Response Genetics Inc (RGDXQ) Response Genetics Inc (RGDXQ)